학술논문

Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks
Document Type
Article
Source
In Journal of Hepatology February 2016 64(2):301-307
Subject
Language
ISSN
0168-8278